Advertisement

Topics

Gene Therapy Systems (GTS) Company Profile

04:16 EDT 19th March 2019 | BioPortfolio

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

Location

10190 Telesis Court
San Diego
CA
92121
United States of America

Contact

Phone: (858)-457-1919
Fax: 858-623-9494 or 858-558-3617
Email: kmasri@geneTherapysystems.com


News Articles [3328 Associated News Articles listed on BioPortfolio]

Science Saturday: Potential and pitfalls of gene therapy

Research is advancing gene therapy as a possible treatment or eventual cure for genetic diseases that bedevil modern science. Gene therapy was conceived over 20 years ago, and until recently, remained...

Manufacturing: The Next Bottleneck in Gene Therapy

Gene therapy is slowly stepping out of its niche, as new scientific insights and lessons learned from early-stage failures have led to several approvals. Now, manufacturing of the viruses used in gene...

Engineering a Way to Prevent an Immune Response to Gene Therapy in Mice

NewsResearchers have demonstrated that gene therapy can be effective without causing a dangerous side effect common to all gene therapy: an autoimmune reaction.

Trend Chart on Innovative Biotherapies – February 11th, 2019

 FEATURE STORY ● Luxturna®: FDA documents reveal the value of a costly gene therapy GENE THERAPY ● The application of Adeno-Associated Viral vector gene therapy to the treatment of Fragile X Sy...

Global Gene Therapy Market Report - 2026

LONDON, Oct. 18, 2018 /PRNewswire/ -- Gene therapy is an experimental technique that encompasses the replacement of mutated genes with healthy genes. Gene therapy is Read more...

RNA-Based Gene Therapy Can Be Turned ON or OFF via Synbio Switches

DNA-based gene therapy, the usual kind of gene therapy, is hard to deliver compared to RNA-based gene therapy. New DNA must enter the nucleus after being transported by nanoparticles or viral vectors,...

Scientists engineer way to prevent immune response to gene therapy in mice

Researchers have demonstrated that gene therapy can be effective without causing a dangerous side effect common to all gene therapy: an autoimmune reaction to the normal protein, which the patient's i...

Liver Gene Therapy 8 Times Stronger Than Usual

Synpromics and UniQure have unveiled new technology for precise genetic control that could make gene therapy safer and more precise. The team has developed a gene therapy system that is highly selecti...

Drugs and Medications [5 Associated Drugs and Medications listed on BioPortfolio]

Oxygen compressed gas [dallas life support systems inc]

NA

Anticoagulant citrate dextrose a acd-a [arteriocyte medical systems, inc.]

Anticoagulant Citrate Dextrose Solution,Solution A, USP

R-gene [pharmacia and upjohn company llc]

R-Gene 10Arginine Hydrochloride Injection, USP

Oxygen [biomedics systems, inc.]

Oxygen

Anticoagulant citrate dextrose a [citra labs]

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

PubMed Articles [5687 Associated PubMed Articles listed on BioPortfolio]

Polycations for Gene Delivery: Dilemmas and Solutions.

Gene therapy has been a promising strategy for treating numerous gene-associated human diseases by altering specific gene expressions in pathological cells. Application of non-viral gene delivery is h...

Branch-PCR constructed TP53 gene nanovector for potential cancer therapy.

A novel and efficient branch PCR strategy has been used to construct a TP53 gene nanovector based on a pair of trimers as primers, which showed unique advantages compared to other existing systems for...

Enhancing the In Vitro and In Vivo Stabilities of Polymeric Nucleic Acid Delivery Nanosystems.

Gene therapy holds great promise for various medical and biomedical applications. Nonviral gene delivery systems formed by cationic polymer and nucleic acids (e.g., polyplexes) have been extensively i...

Advances in the techniques and methodologies of cancer gene therapy.

Cancer is the second leading cause of mortality worldwide after cardiovascular diseases, predominantly due to the lack of early symptoms and early diagnosis, and high relapse rate after radical surger...

The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world.

In this first in a series of round table meetings, the 1st World Federation of Hemophilia Gene Therapy Round Table was convened to initiate a global dialogue on the expected challenges and opportuniti...

Clinical Trials [5220 Associated Clinical Trials listed on BioPortfolio]

RGX-111 Gene Therapy in Patients With MPS I

RGX-111 is a gene therapy which is intended to deliver a functional copy of the α-L-iduronidase (IDUA) gene to the central nervous system. This is a safety and dose ranging study to deter...

Lentiviral Gene Therapy for X-ALD

This is a Phase I/II clinical trial of gene therapy for treating X-linked adrenoleukodystrophy using a high-safety, high-efficiency, self-inactivating lentiviral vector TYF-ABCD1 to functi...

Gene Therapy in Treating Patients With Cancer of The Liver

RATIONALE: Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy with the p5...

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

OBJECTIVES: I. Develop an approach for treating patients with homozygous familial hypercholesterolemia using gene therapy with autologous hepatocytes transduced with a normal low-density...

RGX-121 Gene Therapy in Patients With MPS II (Hunter Syndrome)

RGX-121 is a gene therapy which is intended to deliver a functional copy of the iduronate-2-sulfatase (IDS) gene to the central nervous system. This study is a safety and dose ranging stud...

Companies [2697 Associated Companies listed on BioPortfolio]

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is ...

Karolinska Institute

The primary objectives of the European Society of Gene Therapy (ESGT) are to promote basic and clinical research in gene therapy, to promote education and the exchange of information and technology re...

Dimension Therapeutics

Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. Launched by Fidelity Biosciences in 2013, the Dimension team compris...

Myonexus Therapeutics

Myonexus Therapeutics is a clinical stage, rare disease gene therapy company developing first ever treatments for limb girdle muscular dystrophies (LGMDs) based on research at Nat...

Talee Bio, Inc.

Talee Bio is a development stage biopharmaceutical company focused on developing gene therapy products for the treatment of cystic fibrosis. The company is developing two inhaled ...

More Information about "Gene Therapy Systems (GTS)" on BioPortfolio

We have published hundreds of Gene Therapy Systems (GTS) news stories on BioPortfolio along with dozens of Gene Therapy Systems (GTS) Clinical Trials and PubMed Articles about Gene Therapy Systems (GTS) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Gene Therapy Systems (GTS) Companies in our database. You can also find out about relevant Gene Therapy Systems (GTS) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record